News Sentiment

MDLN sentiment intelligence

Medline Inc. Class A Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 45 Balanced news tone 61 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 41.04 Week of 10 Jul 2026
Weighted tone 45/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 61

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend inactive

-5.0% over one week, +12.1% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Bessemer Group Inc. Grows Stake in Medline $MDLN

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction -5.0% Price reacting lower
Trend fit Trend inactive 12.1% over four weeks
Fair value -2.7% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 37
Negative 15

Relevance

Why the article matched

Direct first
Direct company coverage 61
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
Stock Titan 10
NewMediaWire 8
MarketBeat 4
The Globe and Mail 3
PR Newswire 3
TradingView 3
MT Newswires 2

Event Lens

What the news is about

Classified themes
Market update 35
Regulatory and legal 9
Earnings 9
Deals and strategy 3
Analyst action 3
Guidance 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 61
NewMediaWire Direct company coverage

Kaplan Fox & Kilsheimer LLP Alerts Medline Inc. (NASDAQ: MDLN) Investors to a Securities Investigation

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (NASDAQ: MDLN) after the FDA issued a warning letter on May 28, 2026, citing "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals."

Tone
Negative 28/100
Event
Regulatory and legal
Published
15 Jul 2026 21:11
Source
NewMediaWire
The Globe and Mail Direct company coverage

Analysts Offer Insights on NA Companies: CoreWeave (CRWV) and Medline (MDLN)

Analysts have provided their insights on CoreWeave (CRWV) and Medline (MDLN). Bernstein maintained a Sell rating on CoreWeave with a $67.00 price target, while TipRanks indicates a Moderate Buy consensus with an average target of $132.35. Truist Financial and RBC Capital both mai

Tone
Positive 71/100
Event
Analyst action
Published
10 Jul 2026 20:10
Source
The Globe and Mail
Stock Titan Direct company coverage

COO Stephen Miller retiring from Medline (Nasdaq: MDLN) in 2026

Medline Inc. (Nasdaq: MDLN) announced that its Chief Operating Officer, Stephen L. Miller, will retire for health-related reasons, effective August 30, 2026. Miller notified the company of his decision on July 7, 2026, and Medline has initiated a search for his successor. This in

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 19:43
Source
Stock Titan
TradingView Direct company coverage

Non-operating income (total) of Medline, Inc. Class A – XETR:L10

This page from TradingView displays the non-operating income (total) for Medline, Inc. Class A, traded on the Deutsche Borse Xetra under the symbol L10. The page shows that the market is closed and there are no current trades. It also highlights various financial data points and

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 04:40
Source
TradingView
The Globe and Mail Direct company coverage

Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm

Kaplan Fox & Kilsheimer LLP is investigating Medline Inc. (NASDAQ: MDLN) for potential securities law violations after the FDA issued a warning letter on June 2, 2026, citing significant violations of good manufacturing practices and failure to investigate discrepancies. Followin

Tone
Negative 28/100
Event
Market update
Published
01 Jul 2026 07:41
Source
The Globe and Mail
NewMediaWire Direct company coverage

Medline Inc. (NASDAQ: MDLN) Faces Possible Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP

Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations by Medline Inc. (NASDAQ: MDLN) after the FDA issued a warning letter citing "significant manufacturing practice violations." Following this news, Medline's stock price dropped by 7.16%. This is the s

Tone
Negative 30/100
Event
Market update
Published
30 Jun 2026 19:10
Source
NewMediaWire
NewMediaWire Direct company coverage

Kaplan Fox Reminds Investors of Medline Inc. (NASDAQ: MDLN) to an Investigation of Possible Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (NASDAQ: MDLN) following a Federal Drug Administration (FDA) warning letter. The FDA cited "significant violations of Current Good Manufacturing Practice regulations" and failure to

Tone
Negative 14/100
Event
Regulatory and legal
Published
29 Jun 2026 17:40
Source
NewMediaWire
TradingView Direct company coverage

Medline, Inc. Class A Actuals & Estimates (FWB:L10)

This article provides an overview of Medline, Inc. Class A stock (L10 on FWB), including its current price, historical performance, and analyst forecasts. It also details financial actuals and estimates such as earnings, revenue, net income, market capitalization, and EBITDA, and

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 15:10
Source
TradingView
FinancialContent Direct company coverage

FinancialContent - Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm

Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations by Medline Inc. (NASDAQ: MDLN) after the FDA issued a warning letter citing "significant violations of Current Good Manufacturing Practice regulations" for finished pharmaceuticals. Following this ne

Tone
Negative 27/100
Event
Market update
Published
27 Jun 2026 07:00
Source
FinancialContent
NewMediaWire Direct company coverage

MEDLINE ALERT: Medline Inc. (NASDAQ: MDLN) Faces Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP

Kaplan Fox & Kilsheimer LLP is investigating Medline Inc. (NASDAQ: MDLN) for potential securities law violations after the FDA issued a warning letter regarding "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals." This FDA acti

Tone
Negative 25/100
Event
Market update
Published
26 Jun 2026 18:40
Source
NewMediaWire
TradingView Direct company coverage

L10 Forecast — Price Target — Prediction for 2027

This article provides a forecast for Medline, Inc. Class A (L10) stock, including a 1-year price target of 44.22 EUR based on 27 analysts' forecasts, with a maximum estimate of 53.83 EUR and a minimum of 34.73 EUR. It also details the company's recent stock performance, current m

Tone
Neutral 50/100
Event
Guidance
Published
26 Jun 2026 13:40
Source
TradingView
FinancialContent Direct company coverage

FinancialContent - Kaplan Fox Encourages Investors of Medline Inc. (NASDAQ: MDLN) to Contact the Firm Regarding an Investigation Into Possible Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating Medline Inc. (NASDAQ: MDLN) for possible securities law violations following a warning letter from the FDA. The FDA cited "significant violations of Current Good Manufacturing Practice regulations" and inadequate investigation into dis

Tone
Negative 28/100
Event
Regulatory and legal
Published
25 Jun 2026 09:30
Source
FinancialContent
The Globe and Mail Direct company coverage

Investors of Medline Inc. (NASDAQ: MDLN) are Encouraged to Contact Kaplan Fox Regarding the Investigation of Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (NASDAQ: MDLN) following a warning letter from the FDA. The FDA letter cited "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals,"

Tone
Negative 14/100
Event
Regulatory and legal
Published
20 Jun 2026 12:10
Source
The Globe and Mail